October 2, 2025Open Access

A 28-Day Oral Toxicity Study in Wistar Rats for a Highly Bioavailable Curcumin Preparation, CAVACURMIN®

View Full Paper

Ask AI

Bookmark

Authors

HZHeiko ZippWacker Group (Germany)MKMarco Kellert NRNatascha Lara Rivera

Discussion

Member takes

Implication

This study evaluates the safety of the high-bioavailability curcumin product, CAVACURMIN®, in Wistar rats, indicating its potential for further evaluation.

Key Points

CAVACURMIN® showed no mortality or systemic toxicity in Wistar rats.
At 3500 mg/kg/day, there were only minor shifts in clinical chemistry, suggesting possible benefits.
The study involved administering doses of 2000 mg/kg/day and 3500 mg/kg/day over 28 days with controls.
These results support that CAVACURMIN® is well tolerated, highlighting its safety for future studies.

Cite This Study

Zipp et al. (2025) studied this question.

synapsesocial.com/papers/68de84bb5b556a9128e1b9df https://doi.org/10.20944/preprints202509.2433.v1

View Full Paper

Ask AI

Bookmark

Implication

This study evaluates the safety of the high-bioavailability curcumin product, CAVACURMIN®, in Wistar rats, indicating its potential for further evaluation.

A 28-Day Oral Toxicity Study in Wistar Rats for a Highly Bioavailable Curcumin Preparation, CAVACURMIN®

Discussion

Member takes

Implication

Key Points

Cite This Study

A 28-Day Oral Toxicity Study in Wistar Rats for a Highly Bioavailable Curcumin Preparation, CAVACURMIN®

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider